How Much Weight Will You Lose on Wegovy?

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that reduces hunger signals and slows stomach emptying, leading to meaningful weight loss for most users. Clinical trials show average losses of 10–15% of starting body weight in the first four months, though individual outcomes vary widely based on genetics, adherence, and personal factors.

Average Semaglutide Weight Loss Timeline

Most users begin noticing appetite suppression within days of starting semaglutide, though measurable weight loss typically appears after 2–3 weeks. By week four, users often report 3–5 pounds lost; by week eight, cumulative loss often reaches 7–12 pounds depending on starting body weight and calorie intake.

The most significant weight loss window occurs between months two and four, when the medication reaches therapeutic dose levels. During this phase, users commonly lose 1.5–2 pounds per week, though losses slow as the body adapts. By month six, most users plateau unless dose is increased or lifestyle interventions intensify.

Factors That Affect How Much Weight You Lose

Your genetics play a substantial role in semaglutide response. People with certain variants in the GLP1R and GIPR genes tend to respond more dramatically to the medication, while others experience more modest weight loss. PlexusDx's Precision Peptide Genetic Test identifies your peptide-pathway variants across 14 pathways and 49 peptides, helping predict your likely response before starting treatment.

Dose escalation, calorie deficit, physical activity, sleep quality, and insulin sensitivity all significantly influence outcomes. Users who maintain a consistent 500–750 calorie daily deficit alongside semaglutide therapy achieve 25–30% body weight reductions over six months, while those without dietary changes see 10–15% losses. Consistency matters more than perfection; sporadic adherence or frequent dose pauses reduce cumulative weight loss.

Comparing Semaglutide to Other GLP-1 Options

Semaglutide and tirzepatide both lower hunger and improve metabolic control, but tirzepatide targets two receptors instead of one, sometimes producing faster results in clinical comparisons. A 2023 trial found tirzepatide users lost approximately 22% of body weight versus 15% for semaglutide users at comparable timepoints, though individual variation remains high.

PlexusDx offers both semaglutide injection (starting at $149/month) and tirzepatide injection (starting at $249/month), allowing you to choose based on your genetic profile, budget, and prior response to similar medications. The Precision Peptide Genetic Test helps identify which compound aligns best with your peptide-pathway physiology, removing guesswork from therapy selection.

Sustaining Long-Term Weight Loss on Semaglutide

Weight loss on semaglutide typically plateaus after six to nine months unless dose increases or behavioral changes occur. Continuing the medication at your effective dose prevents rapid weight regain; studies show users who stop therapy regain 50% of lost weight within a year, while those who maintain treatment preserve most gains.

Building durable habits—consistent meal timing, protein-forward nutrition, regular movement, and adequate sleep—compounds semaglutide's effects and extends results beyond the medication alone. PlexusDx's flat monthly pricing model (your dose may go up, your price won't) removes financial barriers to dose adjustments, ensuring you can escalate as needed to overcome plateaus without escalating costs.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I realistically lose in my first month on semaglutide?

Most users lose 3–8 pounds in month one as appetite suppression begins. Weight loss accelerates in months two and three once the dose reaches therapeutic levels. Individual results depend on your starting weight, calorie intake, and metabolism, but initial momentum typically sustains through month four.

Does semaglutide work better for some people than others?

Yes. Genetic variants in the GLP1R and GIPR genes significantly influence how your body responds to semaglutide. PlexusDx's Precision Peptide Genetic Test identifies these variants and predicts your likely response, helping you decide whether semaglutide or a dual-compound option like tirzepatide is optimal for your biology.

What is PlexusDx semaglutide, and how much does it cost?

PlexusDx Compounded Semaglutide Injection is manufactured by licensed 503A compounding pharmacies and starts at $149 per month—no insurance required, no membership fee. HSA and FSA accounts are eligible, and your price remains flat regardless of dose increases.

Will I regain weight if I stop taking semaglutide?

Most users regain 30–50% of lost weight within 12 months after stopping semaglutide. Maintaining treatment at your effective dose, combined with sustained dietary and exercise habits, is the most reliable way to preserve long-term weight loss. Many users continue semaglutide indefinitely as a chronic weight management strategy.

Can I combine semaglutide with other weight loss medications?

PlexusDx offers GLP-Squared Injection, which combines semaglutide and tirzepatide into one compound, starting at $249/month. This dual-pathway approach may produce faster or greater weight loss than semaglutide alone in certain genetic profiles, identified through your Precision Peptide Genetic Test results.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.